RU93037416A - USE OF IZOXASOL DERIVATIVES FOR THE TREATMENT OF THE SYNDROME OF THE IRRITATION OF A THICK INTESTINUM (MULTIUS COLITIS) AND PHARMACEUTICAL COMPOSITION - Google Patents
USE OF IZOXASOL DERIVATIVES FOR THE TREATMENT OF THE SYNDROME OF THE IRRITATION OF A THICK INTESTINUM (MULTIUS COLITIS) AND PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- RU93037416A RU93037416A RU93037416/14A RU93037416A RU93037416A RU 93037416 A RU93037416 A RU 93037416A RU 93037416/14 A RU93037416/14 A RU 93037416/14A RU 93037416 A RU93037416 A RU 93037416A RU 93037416 A RU93037416 A RU 93037416A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- derivatives
- multius
- izoxasol
- intestinum
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 206010009887 Colitis Diseases 0.000 title 1
- 201000010874 syndrome Diseases 0.000 title 1
- 208000002551 Irritable Bowel Syndrome Diseases 0.000 claims 1
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 claims 1
- 230000001270 agonistic Effects 0.000 claims 1
- 150000002545 isoxazoles Chemical class 0.000 claims 1
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91628192A | 1992-07-17 | 1992-07-17 | |
US07/916,281 | 1992-07-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93037416A true RU93037416A (en) | 1996-03-20 |
RU2127111C1 RU2127111C1 (en) | 1999-03-10 |
Family
ID=25436992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93037416A RU2127111C1 (en) | 1992-07-17 | 1993-07-15 | Use of isoxazole derivatives for treatment of patients with irritable bowel syndrome (mucous colitis) and a pharmaceutical composition |
Country Status (23)
Country | Link |
---|---|
US (1) | US5434174A (en) |
EP (1) | EP0579507B1 (en) |
JP (1) | JPH06166620A (en) |
CN (1) | CN1049336C (en) |
AT (1) | ATE206918T1 (en) |
AU (1) | AU666377B2 (en) |
CA (1) | CA2100399A1 (en) |
CZ (1) | CZ284881B6 (en) |
DE (1) | DE69330926T2 (en) |
DK (1) | DK0579507T3 (en) |
ES (1) | ES2162808T3 (en) |
HK (1) | HK1013795A1 (en) |
HU (1) | HUT68727A (en) |
IL (1) | IL106307A (en) |
MX (1) | MX9304205A (en) |
NO (1) | NO304054B1 (en) |
PH (1) | PH30148A (en) |
PL (1) | PL172494B1 (en) |
PT (1) | PT579507E (en) |
RU (1) | RU2127111C1 (en) |
TW (1) | TW232653B (en) |
UA (1) | UA27720C2 (en) |
ZA (1) | ZA934969B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US5962488A (en) | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
FR2792529B1 (en) * | 1999-04-26 | 2001-09-28 | Sod Conseils Rech Applic | NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING 2-ISOXAZOLE-8-AMINOTETRALINE DERIVATIVES |
UA76130C2 (en) * | 2000-11-20 | 2006-07-17 | Merck Patent Gmbh | Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
WO2004062623A2 (en) * | 2003-01-13 | 2004-07-29 | Dynogen Pharmaceuticals, Inc. | Method of treating functional bowel disorders |
SE0301796D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
SE0301798D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use IV |
SE0301795D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
SE0301794D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use III |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
US7684402B2 (en) | 2006-05-15 | 2010-03-23 | Faraday Technology Corp. | Method and network device for fast look-up in a connection-oriented communication |
CN104884064A (en) | 2012-12-24 | 2015-09-02 | 纽洛佳斯特拉斯公司 | Methods for treating gi tract disorders |
WO2015200369A1 (en) | 2014-06-24 | 2015-12-30 | Neurogastrx, Inc. | Prodrugs of metopimazine |
US10836757B1 (en) | 2020-04-02 | 2020-11-17 | Neurogastrx, Inc. | Polymorphic forms of metopimazine |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK203089A (en) * | 1988-04-28 | 1989-10-29 | Beecham Group Plc | metabolites |
HUT61719A (en) * | 1989-05-31 | 1993-03-01 | Upjohn Co | Process for producing 2-aminotetraline derivatives and pharmaceutical compositions comprising such compounds |
SE8904361D0 (en) * | 1989-12-22 | 1989-12-22 | Astra Ab | NEW CHROMAN AND THIOCHROMAN DERIVATIVES |
US5158956A (en) * | 1990-05-04 | 1992-10-27 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with benzodioxanes |
US5096908A (en) * | 1990-05-04 | 1992-03-17 | Eli Lilly And Company | Method of inhibiting gastric acid secretion |
ZA92767B (en) * | 1991-02-08 | 1993-08-03 | Lilly Co Eli | Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes. |
-
1993
- 1993-04-20 US US08/049,968 patent/US5434174A/en not_active Expired - Fee Related
- 1993-07-05 UA UA93002204A patent/UA27720C2/en unknown
- 1993-07-09 CZ CZ931371A patent/CZ284881B6/en not_active IP Right Cessation
- 1993-07-09 TW TW082105482A patent/TW232653B/zh active
- 1993-07-09 ZA ZA934969A patent/ZA934969B/en unknown
- 1993-07-12 IL IL106307A patent/IL106307A/en not_active IP Right Cessation
- 1993-07-13 CA CA002100399A patent/CA2100399A1/en not_active Abandoned
- 1993-07-13 NO NO932547A patent/NO304054B1/en not_active IP Right Cessation
- 1993-07-13 MX MX9304205A patent/MX9304205A/en not_active IP Right Cessation
- 1993-07-15 RU RU93037416A patent/RU2127111C1/en not_active IP Right Cessation
- 1993-07-15 HU HU9302035A patent/HUT68727A/en unknown
- 1993-07-15 AU AU41993/93A patent/AU666377B2/en not_active Ceased
- 1993-07-15 JP JP5175396A patent/JPH06166620A/en not_active Ceased
- 1993-07-15 PL PL93299690A patent/PL172494B1/en not_active IP Right Cessation
- 1993-07-16 AT AT93305611T patent/ATE206918T1/en not_active IP Right Cessation
- 1993-07-16 ES ES93305611T patent/ES2162808T3/en not_active Expired - Lifetime
- 1993-07-16 DK DK93305611T patent/DK0579507T3/en active
- 1993-07-16 EP EP93305611A patent/EP0579507B1/en not_active Expired - Lifetime
- 1993-07-16 PT PT93305611T patent/PT579507E/en unknown
- 1993-07-16 CN CN93108376A patent/CN1049336C/en not_active Expired - Fee Related
- 1993-07-16 DE DE69330926T patent/DE69330926T2/en not_active Expired - Fee Related
- 1993-09-09 PH PH46496A patent/PH30148A/en unknown
-
1998
- 1998-12-23 HK HK98115190A patent/HK1013795A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93037416A (en) | USE OF IZOXASOL DERIVATIVES FOR THE TREATMENT OF THE SYNDROME OF THE IRRITATION OF A THICK INTESTINUM (MULTIUS COLITIS) AND PHARMACEUTICAL COMPOSITION | |
ZA872867B (en) | 5-arylalkyl-4-alkoxy-2(5h)-furanones,intermediates and processes for the preparation thereof and pharmaceutical compositions containing them | |
GB8826066D0 (en) | New use of 11 28-dioxa-4-azatricyclo(22 3 1 0 4.9)octacos-18-ene derivatives & pharmaceutical compositions | |
DE68908786D1 (en) | Condensed pyrimidine derivatives, processes and intermediates for their preparation and pharmaceutical preparations containing them. | |
OA08581A (en) | Treatment of diseases caused by retroviruses. | |
IL67572A (en) | Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them | |
DE2862419D1 (en) | Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates | |
RU93004445A (en) | NEW 2-CYANO 3-HYDROXYENAMIDE DERIVATIVES, METHOD FOR THEIR RECEPTION, THEIR APPLICATION AS MEDICATION, CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND NEW OBTAINED INTERMEDIATE | |
PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
FI903153A0 (en) | 11B-ARYL-4-ESTRENER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DERAS ANVAENDNING SOM LAEKEMEDEL. | |
IT1190824B (en) | PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT | |
ZA9110018B (en) | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity. | |
ATE56956T1 (en) | (S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE HYDROCHLORIDE MONOHYDRATE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING IT. | |
TR26643A (en) | NEW COMPONENTS, PROCESSES FOR THE PREPARATION OF THEM, THEIR COMPOSITIONS AND THEIR USE AS HERBISIDES. | |
AU7116781A (en) | Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds | |
ATE66230T1 (en) | NEW PYRROLO-BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS. | |
IT1213173B (en) | ANTIBACTERIAL ACTIVITY COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS. | |
NO175745C (en) | Analogous Process for Preparation of Dibenzo (1,5) -Dioxocin-5-One | |
AU561393B2 (en) | Pharmaceutical preparation treating glaucoma + occular hypotension | |
IT8026233A0 (en) | DERIVATIVE OF N-ACETYL-CYSTEINE WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS. | |
IL89335A (en) | 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds | |
IL85651A (en) | Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds | |
IT8721540A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING TRAPIDIL, THEIR PREPARATION PROCEDURE AND THEIR THERAPEUTIC USE. | |
ZA928126B (en) | Use of substituted tetrahydrothiophenes, some of wich are known as medicaments, new active substances and processes for their preparation. | |
ATE42305T1 (en) | ANTIBIOTICS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM. |